Page last updated: 2024-08-23

epirubicin and Cholangiitis, Sclerosing

epirubicin has been researched along with Cholangiitis, Sclerosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Maruyama, S	1

Reviews

1 review(s) available for epirubicin and Cholangiitis, Sclerosing

Article	Year
[Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cholangitis, Sclerosing; Cisplatin; Colorectal Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Nausea; Peptic Ulcer; Vomiting	2003

Article

Year

[Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer].

Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7

Topics: Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cholangitis, Sclerosing; Cisplatin; Colorectal Neoplasms; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Nausea; Peptic Ulcer; Vomiting

2003